Decoding inventive step: Madras High Court establishes economic significance as an independent pillar for inventive step

In a significant development for industrial biotechnology and intellectual property jurisprudence, the Hon’ble High Court of Madras has set aside the Patent Office order refusing a patent to Danish Biotech giant Novozymes A/S. Decided by Hon’ble Mr. Justice Senthilkumar Ramamoorthy on April 1, 2026, the judgment in Novozymes A/S v. The Assistant Controller of Patents and Designs [CMA(PT) No. 19 of 2025] outlines a crucial boundary for learned patent examiners. The ruling reaffirms that economic significance is a standalone parameter for inventive step, and strikes down arbitrary, unreasoned rejections under Section 3 of the Indian Patents Act, 1970.

The innovation at stake

Novozymes A/S had filed an Indian Patent Application (No. 202047008467) titled ‘Ejector Equipped Fermenter.’ Traditional microbial fermentation relies heavily on massive mechanical stirrers to circulate fluid and oxygen. These stirrers demand extensive energy, heavy structural framing to withstand vibrations, and separate, dedicated housing facilities.

Novozymes’ invention fundamentally disrupted this paradigm by replacing heavy mechanical stirrers with fluid injectors and a circulation loop. The technical benefits translated into profound economic advantages:

1. Significantly lower construction costs, due to lighter tank materials.
2. Radically reduced operational expenditures from lower energy consumption.
3. Elimination of the need for specialized housing buildings, allowing equipment sharing.

Despite these advantages, the Assistant Controller rejected the application on February 17, 2025, triggering the appeal to the Madras High Court.

The Controller had refused the application on three primary statutory grounds:

1. Section 2(1)(ja) (Lack of Inventive Step): Grounded on the claim that combining the features was a “routine design choice”.
2. Section 3(d) (Non-Patentability): Characterized the fermenter as a “new form” of a known machine without proving enhanced efficacy.
3. Section 3(f) (Non-Patentability): Declared the apparatus a “mere arrangement” of known devices functioning independently.

Key legal issues & the Court’s comprehensive findings

The Hon’ble Court systematically dismantled the Controller’s objections, establishing vital precedents for how patent applications must be reviewed moving forward:

1. Economic significance is disjunctive and independent

The foundational legal battleground rested on the definition of an Inventive Step under Section 2(1)(ja), which requires an invention to involve: “…technical advance as compared to the existing knowledge or having economic significance or both…”

The Court noted that the Controller completely ignored the empirical data (Example 3, Table 4) submitted by Novozymes, proving lower operating costs and energy conservation. Justice Ramamoorthy emphasized that economic significance is a statutorily recognized, independent ground to establish an inventive step. If an invention yields profound cost and energy efficiencies, the Patent Office must evaluate whether those specific economic benefits would have been obvious to a Person Skilled in the Art (PSITA), rather than just evaluating the physical components.

2. Misapplication of chemical exclusions to mechanical devices

The Controller attempted to leverage Section 3(d), historically used to prevent the evergreening of pharmaceutical or chemical substances, by asserting it applies to a new machine unless a new product or reactant is introduced.

The Court clarified that the application of Section 3(d) to a purely mechanical apparatus (like a structural fermenter tank) was highly legally ambiguous and completely unreasoned in the impugned order, indicating that examiners cannot blindly map chemical standards onto mechanical engineering patents.

3. The death of the ‘feature-comparison table’ as an obviousness analysis

In a stark warning to the Patent Office against taking procedural shortcuts, the Court held that a mere comparison table matching the features of an invention against prior art documents (D1-D4) is entirely insufficient to establish obviousness.

The Court ruled that the Controller must provide a “speaking order” demonstrating the exact motivation or impulse that would lead a PSITA to combine those disparate prior arts to arrive at the claimed invention. Without a clear path of logic, a rejection is merely based on hindsight bias.

4. Condemnation of unreasoned’ section 3(f)’ slaps

The Court found that the Controller’s rejection under Section 3(f) (mere arrangement of known devices) lacked substantive reasoning. For a Section 3(f) objection to hold weight, the examiner must explicitly detail how the components are performing independently without a unified, cooperative technical result.

Conclusion

The Novozymes judgment is a breath of fresh air for industries where technical leaps are heavily tied to process optimizations, scalability, and cost reduction (such as green tech, biotech, and heavy manufacturing). By enforcing the “or” in Section 2(1)(ja), the Madras High Court ensures that innovators who spend millions making industrial processes cleaner, cheaper, and commercially viable are not denied protection by a rigid, checkbox-ticking patent administration.

← Back to News